Durotomy is a common neurosurgical complication involving a tear in the dura mater, the protective membrane surrounding the ...
Revolutionary technologies like pulsed field ablation and structural heart therapies are driving rapid market expansion.
Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...
Haemonetics' acquisition of Vivasure adds PerQseal Elite, advancing large-bore closure solutions for TAVR and EVAR markets.
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular ...
Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical.
As of Thursday, January 08, Teleflex Incorporated’s TFX share price has dipped by 12.75%, which has investors questioning if ...
Boston-headquartered medical device group Haemonetics agrees to pay €100m upfront for Enterprise Ireland-backed company ...
Life Seal Vascular Announces Initial Implants of the Cygnum™ Aneurysm Sac Management Device in Japan
LAKE FOREST, CA, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Life Seal Vascular, Inc., a company pioneering next-generation solutions to improve the long ...
SAN FRANCISCO, CA—A novel percutaneous ventricular assist device (pVAD) appears to offer comparable safety to an intra-aortic balloon pump (IABP) when offering hemodynamic stabilization in elective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results